Literature DB >> 22198208

Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research.

Alesia Ivashkevich1, Christophe E Redon, Asako J Nakamura, Roger F Martin, Olga A Martin.   

Abstract

Formation of γ-H2AX in response to DNA double stranded breaks (DSBs) provides the basis for a sensitive assay of DNA damage in human biopsies. The review focuses on the application of γ-H2AX-based methods to translational studies to monitor the clinical response to DNA targeted therapies such as some forms of chemotherapy, external beam radiotherapy, radionuclide therapy or combinations thereof. The escalating attention on radiation biodosimetry has also highlighted the potential of the assay including renewed efforts to assess the radiosensitivity of prospective radiotherapy patients. Finally the γ-H2AX response has been suggested as a basis for an in vivo imaging modality.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198208      PMCID: PMC3329565          DOI: 10.1016/j.canlet.2011.12.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  140 in total

Review 1.  Usefulness and limits of biological dosimetry based on cytogenetic methods.

Authors:  A Léonard; J Rueff; G B Gerber; E D Léonard
Journal:  Radiat Prot Dosimetry       Date:  2005       Impact factor: 0.972

Review 2.  Microscopic imaging of DNA repair foci in irradiated normal tissues.

Authors:  Nirmal Bhogal; Farid Jalali; Robert G Bristow
Journal:  Int J Radiat Biol       Date:  2009-09       Impact factor: 2.694

3.  Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography.

Authors:  Michael P Macmanus; Rodney J Hicks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

4.  How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

Authors:  S L Tucker; F B Geara; L J Peters; W A Brock
Journal:  Radiother Oncol       Date:  1996-02       Impact factor: 6.280

5.  Detection of clustered DNA lesions: Biological and clinical applications.

Authors:  Alexandros Georgakilas
Journal:  World J Biol Chem       Date:  2011-07-26

6.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

7.  Quantitative, noninvasive imaging of radiation-induced DNA double-strand breaks in vivo.

Authors:  Wenrong Li; Fang Li; Qian Huang; Jingping Shen; Frank Wolf; Yujun He; Xinjian Liu; Y Angela Hu; Joel S Bedford; Chuan-Yuan Li
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

8.  DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures.

Authors:  Michael A Kuefner; Saskia Grudzenski; Siegfried A Schwab; Melanie Wiederseiner; Martina Heckmann; Werner Bautz; Markus Lobrich; Michael Uder
Journal:  Invest Radiol       Date:  2009-08       Impact factor: 6.016

9.  Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.

Authors:  Bart Cornelissen; Veerle Kersemans; Sonali Darbar; James Thompson; Ketan Shah; Kate Sleeth; Mark A Hill; Katherine A Vallis
Journal:  Cancer Res       Date:  2011-05-17       Impact factor: 12.701

10.  An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans.

Authors:  Ismail Hassan Ismail; Tabasum Imran Wadhra; Ola Hammarsten
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

View more
  135 in total

1.  APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency.

Authors:  Cheng-Yu Tsai; Si Sun; Hongying Zhang; Andrea Local; Yongxuan Su; Larry A Gross; William G Rice; Stephen B Howell
Journal:  Mol Cancer Ther       Date:  2018-04-06       Impact factor: 6.261

2.  Evaluation of Severe Combined Immunodeficiency and Combined Immunodeficiency Pediatric Patients on the Basis of Cellular Radiosensitivity.

Authors:  Pavel Lobachevsky; Lisa Woodbine; Kuang-Chih Hsiao; Sharon Choo; Chris Fraser; Paul Gray; Jai Smith; Nickala Best; Laura Munforte; Elena Korneeva; Roger F Martin; Penny A Jeggo; Olga A Martin
Journal:  J Mol Diagn       Date:  2015-07-04       Impact factor: 5.568

Review 3.  Histone variants: emerging players in cancer biology.

Authors:  Chiara Vardabasso; Dan Hasson; Kajan Ratnakumar; Chi-Yeh Chung; Luis F Duarte; Emily Bernstein
Journal:  Cell Mol Life Sci       Date:  2013-05-08       Impact factor: 9.261

4.  Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Authors:  Morihiko Sagawa; Hiroto Ohguchi; Takeshi Harada; Mehmet K Samur; Yu-Tzu Tai; Nikhil C Munshi; Masahiro Kizaki; Teru Hideshima; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2017-04-25       Impact factor: 12.531

5.  PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.

Authors:  James C Knight; Caitríona Topping; Michael Mosley; Veerle Kersemans; Nadia Falzone; José M Fernández-Varea; Bart Cornelissen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-02       Impact factor: 9.236

6.  Elevated HMGN4 expression potentiates thyroid tumorigenesis.

Authors:  Jamie Kugler; Yuri V Postnikov; Takashi Furusawa; Shioko Kimura; Michael Bustin
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

Review 7.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

8.  Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.

Authors:  Zhishan Wang; Jianjun Wu; Brock Humphries; Kazuya Kondo; Yiguo Jiang; Xianglin Shi; Chengfeng Yang
Journal:  Toxicol Appl Pharmacol       Date:  2018-01-31       Impact factor: 4.219

9.  Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.

Authors:  Pavel Lobachevsky; Trevor Leong; Patricia Daly; Jai Smith; Nickala Best; Jonathan Tomaszewski; Ella R Thompson; Na Li; Ian G Campbell; Roger F Martin; Olga A Martin
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

Review 10.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.